세계의 면역글로불린 E(IgE) 알레르기 혈액 검사 시장 보고서(2025년)
Immunoglobulin E (IgE) Allergy Blood Tests Global Market Report 2025
상품코드 : 1825771
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,430,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,294,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,159,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

면역글로불린 E(IgE) 알레르기 혈액 검사 시장 규모는 향후 몇 년 동안 강력한 성장이 예상됩니다. 2029년에는 CAGR 7.8%로 486억 7,000만 달러로 성장할 것입니다. 예측 기간 동안의 성장은 알레르기 연구 개발에 대한 투자 증가, 현장 검사 도입 확대, 조기 진단 및 개입에 대한 관심 증가, 종합적인 알레르기 프로파일링에 대한 수요 증가, 알레르기 진단에 대한 인공지능의 통합 등에 기인합니다. 예측 기간의 주요 동향으로는 멀티플렉스 알레르기 검사의 등장, 알레르기 진료를 위한 원격의료의 활용, 알레르기 질환의 신규 바이오마커 개발, 소비자 직접 알레르기 검사 서비스 확대, 개인별 맞춤 알레르기 관리를 위한 빅데이터 분석의 통합 등이 있습니다.

향후 5년간 7.8%의 성장률 전망은 지난번 예측보다 0.7% 소폭 하락한 수치입니다. 이 감소는 주로 미국과 다른 국가 간의 관세의 영향에 기인합니다. 관세 장벽은 독일과 일본에서 조달하는 IgE 특이적 면역 어세이 키트의 비용을 상승시키고, 알레르기 진단을 지연시키며, 면역학 연구소의 지출을 증가시킴으로써 미국을 괴롭힐 것으로 예상됩니다. 또한, 상호 관세와 무역 긴장과 제한의 증가로 인한 세계 경제와 무역에 대한 악영향으로 인해 그 영향은 더욱 광범위하게 나타날 것으로 보입니다.

알레르기 유병률의 증가는 향후 몇 년 동안 IgE 알레르기 혈액 검사 시장의 성장을 촉진할 것으로 예상됩니다. 알레르기는 보통 대부분의 사람에게 무해한 물질에 대해 면역체계가 과도하게 반응하여 재채기, 가려움증, 호흡기질환 등의 증상을 유발하는 것으로 발생합니다. 알레르기 환자의 증가는 생활습관의 변화, 환경오염, 유전적 요인에 기인한다고 볼 수 있습니다. IgE 알레르기 혈액검사는 혈액 내 면역글로블린 E(IgE) 항체의 농도를 측정하여 특정 알레르겐을 확인하는 검사로 천식, 알레르기 비염, 음식물 알레르기 등 알레르기 질환의 진단과 관리에 도움이 됩니다. 예를 들어, 미국 천식 및 알레르기 재단이 2022년 3월 발표한 'AAFA 2022 Allergy Capitals Report'에 따르면, 일반적으로 꽃가루 알레르기로 알려진 계절성 알레르기성 비염은 가장 널리 퍼진 알레르기 질환 중 하나입니다. 성인의 약 7.7%, 소아의 약 7.2%가 이 질환으로 진단받고 있습니다. 따라서 알레르기 유병률의 증가는 IgE 알레르기 혈액 검사 시장의 성장을 촉진하고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세, 그리고 코로나와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별·국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 개요

제31장 기타 주요 기업과 혁신적 기업

제32장 세계의 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병

제34장 최근의 시장 동향

제35장 시장 잠재력이 높은 국가, 부문, 전략

제36장 부록

KSM
영문 목차

영문목차

Immunoglobulin E (IgE) allergy blood tests are designed to measure the levels of IgE antibodies present in the bloodstream, which are generated by the immune system in response to allergens. These tests play a crucial role in identifying the particular allergens responsible for triggering allergic reactions in individuals. Healthcare providers rely on these test results to pinpoint the allergens causing allergic symptoms, enabling them to tailor treatment plans accordingly and thereby improving patient management and overall quality of life.

The primary product categories of IgE allergy blood tests include assays and kits, which comprise enzyme-linked immunosorbent assay (ELISA) testing kits, fluorescent enzyme immunoassays (FEIA) testing kits, and chemiluminescent immunoassays (CLIA). These kits and assays consist of tools and substances utilized to analyze biological samples for specific allergens or conditions. They serve diverse applications, encompassing aero allergies, indoor allergies, outdoor allergies, food allergies, venoms, medicine allergies, and latex/metal allergies. End users of these products span diagnostic laboratories, specialty clinics, hospitals, and research and academic centers, reflecting a wide array of healthcare and scientific facilities.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The immunoglobulin E (IgE) allergy blood tests market research report is one of a series of new reports from The Business Research Company that provides immunoglobulin E (IgE) allergy blood tests market statistics, including the immunoglobulin E (IgE) allergy blood tests industry global market size, regional shares, competitors with immunoglobulin E (IgE) allergy blood tests market share, detailed immunoglobulin E (IgE) allergy blood tests market segments, market trends, and opportunities, and any further data you may need to thrive in the immunoglobulin E (IgE) allergy blood tests industry. This immunoglobulin E (IgE) allergy blood tests market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The immunoglobulin e (ige) allergy blood tests market size has grown strongly in recent years. It will grow from $33.24 billion in 2024 to $36.06 billion in 2025 at a compound annual growth rate (CAGR) of 8.5%. The growth in the historic period can be attributed to technological advancements, increasing allergy prevalence, growing demand for personalized medicine, expanding healthcare infrastructure, and rising awareness about allergy diagnosis and treatment.

The immunoglobulin e (ige) allergy blood tests market size is expected to see strong growth in the next few years. It will grow to $48.67 billion in 2029 at a compound annual growth rate (CAGR) of 7.8%. The growth in the forecast period can be attributed to rising investments in allergy research and development, expanding adoption of point-of-care testing, increasing focus on early diagnosis and intervention, growing demand for comprehensive allergy profiling, and integration of artificial intelligence in allergy diagnostics. Major trends in the forecast period include emergence of multiplex allergy testing, utilization of telemedicine for allergy consultations, development of novel biomarkers for allergic diseases, expansion of direct-to-consumer allergy testing services, and integration of big data analytics for personalized allergy management.

The forecast of 7.8% growth over the next five years reflects a modest reduction of 0.7% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff barriers are expected to hamper the U.S. by increasing the cost of IgE-specific immunoassay kits sourced from Germany and Japan, thereby delaying allergy diagnosis and elevating immunology lab expenditures. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The growing prevalence of allergies is expected to drive the growth of the IgE allergy blood tests market in the coming years. Allergies occur when the immune system reacts excessively to substances that are usually harmless to most people, leading to symptoms such as sneezing, itching, and respiratory problems. The rise in allergy cases can be attributed to lifestyle changes, environmental pollution, and genetic factors. IgE allergy blood tests are used to identify specific allergens by measuring the levels of Immunoglobulin E (IgE) antibodies in the blood, which helps in diagnosing and managing allergic conditions like asthma, allergic rhinitis, and food allergies. For example, according to the AAFA 2022 Allergy Capitals Report released by the Asthma and Allergy Foundation of America in March 2022, seasonal allergic rhinitis, commonly known as hay fever, is among the most widespread allergic conditions. Approximately 7.7% of adults and 7.2% of children have been diagnosed with this condition. Thus, the increasing prevalence of allergies is fueling the growth of the IgE allergy blood tests market.

Innovations in the IgE allergy blood test market focus on developing AI-powered allergy tests to enhance accuracy, efficiency, and scalability in allergy diagnostics. These tests leverage artificial intelligence algorithms and machine learning techniques to analyze allergy-related data and provide valuable insights into individual allergic sensitivities. For example, Dr. Dangs Lab introduced 'Allergynius Dx,' a molecular allergy diagnostics test based on Microarray using Nano Particles, capable of testing 163 food and respiratory allergens. This advancement signifies a significant leap in allergy testing, offering a comprehensive approach to identifying and managing allergies across a broad spectrum of allergens.

In October 2022, Sebia, a France-based provider of equipment and reagents for clinical protein electrophoresis, acquired Zeus Scientific Inc. for an undisclosed amount. This acquisition is intended to enhance Sebia's product range and expand its market footprint in the United States. By incorporating Zeus Scientific's expertise in immunofixation electrophoresis and related diagnostics, Sebia aims to strengthen its portfolio within the clinical laboratory sector. Zeus Scientific Inc. is a US-based manufacturer of medical equipment.

Major companies operating in the immunoglobulin E (IgE) allergy blood tests market are Roche Holdings Inc., Thermo Fisher Scientific Inc, Abbott Laboratories, Novartis AG, Siemens Healthineers Pvt Ltd, BD Biosciences, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Eurofins Scientific SE, BioMerieux SA, Beckman Coulter Inc., Sysmex Corporation, Bio-Rad Laboratories Inc., Bio-Techne Corporation, GenScript Biotech Corporation, Randox Laboratories Ltd, Neogen Corporation, Invitae Corporation, Quanterix Corporation, Omega Diagnostics Plc, AESKU Group GmbH, Hitachi Chemical Diagnostics Inc., HYCOR Biomedical LLC, Amerimmune LLC

North America was the largest region in the immunoglobulin E (IgE) allergy blood tests market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the immunoglobulin E (IgE) allergy blood tests market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the immunoglobulin E (IgE) allergy blood tests market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The immunoglobulin E (IgE) allergy blood tests market consists of sales of custom panels, and component-resolved diagnostics (CRD). Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Immunoglobulin E (IgE) Allergy Blood Tests Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on immunoglobulin e (ige) allergy blood tests market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for immunoglobulin e (ige) allergy blood tests ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The immunoglobulin e (ige) allergy blood tests market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Immunoglobulin E (IgE) Allergy Blood Tests Market Characteristics

3. Immunoglobulin E (IgE) Allergy Blood Tests Market Trends And Strategies

4. Immunoglobulin E (IgE) Allergy Blood Tests Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Immunoglobulin E (IgE) Allergy Blood Tests Growth Analysis And Strategic Analysis Framework

6. Immunoglobulin E (IgE) Allergy Blood Tests Market Segmentation

7. Immunoglobulin E (IgE) Allergy Blood Tests Market Regional And Country Analysis

8. Asia-Pacific Immunoglobulin E (IgE) Allergy Blood Tests Market

9. China Immunoglobulin E (IgE) Allergy Blood Tests Market

10. India Immunoglobulin E (IgE) Allergy Blood Tests Market

11. Japan Immunoglobulin E (IgE) Allergy Blood Tests Market

12. Australia Immunoglobulin E (IgE) Allergy Blood Tests Market

13. Indonesia Immunoglobulin E (IgE) Allergy Blood Tests Market

14. South Korea Immunoglobulin E (IgE) Allergy Blood Tests Market

15. Western Europe Immunoglobulin E (IgE) Allergy Blood Tests Market

16. UK Immunoglobulin E (IgE) Allergy Blood Tests Market

17. Germany Immunoglobulin E (IgE) Allergy Blood Tests Market

18. France Immunoglobulin E (IgE) Allergy Blood Tests Market

19. Italy Immunoglobulin E (IgE) Allergy Blood Tests Market

20. Spain Immunoglobulin E (IgE) Allergy Blood Tests Market

21. Eastern Europe Immunoglobulin E (IgE) Allergy Blood Tests Market

22. Russia Immunoglobulin E (IgE) Allergy Blood Tests Market

23. North America Immunoglobulin E (IgE) Allergy Blood Tests Market

24. USA Immunoglobulin E (IgE) Allergy Blood Tests Market

25. Canada Immunoglobulin E (IgE) Allergy Blood Tests Market

26. South America Immunoglobulin E (IgE) Allergy Blood Tests Market

27. Brazil Immunoglobulin E (IgE) Allergy Blood Tests Market

28. Middle East Immunoglobulin E (IgE) Allergy Blood Tests Market

29. Africa Immunoglobulin E (IgE) Allergy Blood Tests Market

30. Immunoglobulin E (IgE) Allergy Blood Tests Market Competitive Landscape And Company Profiles

31. Immunoglobulin E (IgE) Allergy Blood Tests Market Other Major And Innovative Companies

32. Global Immunoglobulin E (IgE) Allergy Blood Tests Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Immunoglobulin E (IgE) Allergy Blood Tests Market

34. Recent Developments In The Immunoglobulin E (IgE) Allergy Blood Tests Market

35. Immunoglobulin E (IgE) Allergy Blood Tests Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기